Dupilumab may be beneficial for severe asthma patients with high FeNO And low blood eosinophil counts in real world observational study.
Year: 2023
Type: conference-abstract
Source: European Respiratory Journal
Institution: Saitama Medical University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4387982025
